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The development and introduction of radiofrequency ablation devices allowed maze procedure to be
performed safely and easily, further enabling off-pump pulmonary vein isolation through mini-
thoracotomy or thoracoscopy. The outcomes of the maze procedure include the prevention of stroke
and other complications related to atrial ﬁbrillation (AF), improvement in cardiac performance, and
relief of symptoms. The indications for the maze procedure have been discussed on the basis of
available evidence. Pulmonary vein isolation has been shown to be effective in most patients with
paroxysmal AF, and can be performed with both endocardial catheter ablation and minimally invasive
epicardial ablation. These 2 modalities should be compared in terms of the success rate, occurrence of
cerebral microembolic signals, capability adding other lesions indicated for persistent or long-standing
persistent AF, and closure of the left atrial appendage. Noncontinuous or nontransmural lines of
conduction block as a result of incomplete ablation can result in the recurrence of AF and induction of
atrial tachycardia. Intraoperative veriﬁcation of a conduction block across the ablation lines is
recommended to prevent these complications. Volume reduction of the enlarged left atrium or a box
lesion to isolate the entire posterior left atrium may be effective in patients with a dilated left atrium,
but the potentially impaired atrial transport function should be considered. Mapping of active
ganglionated plexi and their ablation may improve the outcome of the procedure; however, the
long-term effect on AF and autonomic nerve activities should be examined. Because the mechanism
underlying AF varies in each patient, a tailor-made therapy, using a stepwise approach, with a hybrid
procedure combining epicardial and endocardial ablation offers promising prospects in the nonphar-
macological treatment of AF.
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It has been a quarter of a century since the maze procedure was
ﬁrst performed in a patient with atrial ﬁbrillation (AF). Initially, allrt Rhythm Society. Published by E
: þ81 3 5685 0985.lines of conduction block were created by a ‘‘cut-and-sew’’ techni-
que in conjunction with cryoablation at the atrioventricular annuli.
The use of the maze procedure has been limited by its complexity,
the potential risk of bleeding, and the prolonged ischemic time.
However, the introduction of radiofrequency (RF) ablation devices
enabled performing the procedure in a minimally invasive manner,
and it is now widely performed as a standard surgical procedure.lsevier B.V. All rights reserved.
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investigated with regard to cardiac function, prevention of
thromboembolism, long-term mortality, quality of life, and
others. Many studies have demonstrated that the maze procedure
relieves symptoms, decreases the morbidities associated with AF,
and improves patient survival. The indications and recommenda-
tions for the procedure have been published as a guideline or a
consensus statement.
The establishment of a minimally invasive procedure for AF
will beneﬁt patients with lone AF and without any structural
heart disease. An off-pump and beating heart pulmonary vein
(PV) isolation procedure with a bipolar RF ablation device,
through a small thoracotomy or thoracoscopy, has been devel-
oped and shown to be effective in some patients, mainly those
with paroxysmal AF. Currently, PV isolation can be effectively
attained with a high success rate by catheter ablation, particularly
in patients with paroxysmal AF. A prospective study will be
directed toward the modiﬁcation of the PV isolation procedure
for terminating AF, even the persistent or long-standing
persistent AF.
The surgical and catheter approaches both have advantages
and limitations in AF ablation. PV isolation and excision of the left
atrial appendage can be easily performed through small thora-
cotomy or thoracoscopy. Catheter ablation is more suited for
isthmus or focal ablation guided by electrophysiological ﬁndings.
A hybrid therapy combining these approaches may be a promis-
ing prospect.
The use of ablation devices simpliﬁes the procedure, and
decreases the procedure time and the risk of bleeding. However,
these ablation devices can create nontransmural or noncontin-
uous lines of conduction block, and result in failure to convert AF
or induce reentrant atrial tachycardia (AT) postoperatively.
Further improvement of these ablation devices and technical
artiﬁces, including intraoperative veriﬁcation of a conduction
block, are mandatory to decrease the incidence of incomplete
conduction blocks.
The maze procedure may not be able to cure AF in a certain
group of patients, including those with a severely dilated left
atrium, long-lasting AF, and low-amplitude atrial activity on the
electrocardiogram. Volume reduction of the left atrium in addi-
tion to the maze procedure may lessen the blood stasis in the left
atrium and increase the chance of terminating AF even in this
subgroup of patients. The more the atrial myocardium is isolated,
such as in the box lesion set, the higher the chance for AF to be
terminated, but the lesser the recovery of the atrial transport
function.
Increased autonomic nervous activity is known to play an
important role in the initiation and maintenance of AF. Recently,
identiﬁcation of active ganglionated plexi (GP) and their ablation,
with or without the maze procedure, has been shown to con-
tribute to the elimination of AF. The long-term effect of GP
ablation on the maintenance of sinus rhythm, as well as the
adverse effect on the physiologic variability of heart rate, will
need further investigation.
This review will describe the recent progress and future
perspective in surgery for AF.Fig. 1. (A) Rate of freedom from recurrence of atrial ﬁbrillation (AF). (B) Rate of
freedom from cerebral infarction. Open circle: cerebral infarction in patient with
sinus rhythm. Closed circle: cerebral infarction in patient with recurrent AF. (Cited
from Ref. [5] with permission: J Thorac Cardiovasc Surg. 2010;140:1332-7.).2. Effects of the maze procedure and guidelines
A number of studies have examined the effects of the maze
procedure, including parameters such as the relief of symptoms,
incidence of hospital readmission, morbidities associated with AF,
quality of life, incidence of thromboembolism, and mortality.
Whereas the relief of symptoms such as palpitations is a simple
aim of the maze procedure for patients with paroxysmal AF, theprevention of stroke and long-term survival are the most impor-
tant goals of any treatment for both paroxysmal and chronic AF.
The prevention of stroke has been recognized as an important
reason for performing the maze procedure since the era of the
cut-and-sew technique [1]. Lall et al. [2] demonstrated that the
early results, such as 30-d mortality, early atrial tachyarrhyth-
mias, late stroke, and survival, after the maze procedure with a
bipolar RF ablation device were similar to those with the cut-and-
sew technique. Beukema et al. [3] examined the intermediate to
long-term results after the maze procedure with an irrigated
unipolar RF ablation device in 258 patients with structural heart
disease and permanent AF. Oral anticoagulation drugs were taken
by 99% of these patients. Stroke was reported in 4 patients. The
mortality rate was 28.3% during a mean follow-up of 43.7725.9
months. The postoperative rhythm was not predictive of all-cause
mortality, cardiac mortality, and stroke. Kim et al. [4] investigated
whether the type of the mitral surgery affects the outcome in 435
patients who underwent the maze procedure concomitant to
either a mitral repair or mitral replacement. No signiﬁcant
differences were found between the types of mitral surgery in
terms of survival, stroke incidence, or sinus rhythm restoration
rate. More recently, Fujita et al. [5] evaluated the long-term
outcomes of a combined mitral repair and maze procedure for
patients with nonrheumatic mitral regurgitation and chronic AF.
The 15-year survival was 71%, and 11 thromboembolic episodes
were detected during a mean follow-up period of 7.474.3 years,
of which 7 occurred in patients with recurrent AF (Fig. 1).
A guideline for AF surgery was published by the Japanese
Circulation Society in 2000, and revised in 2011 [6]. The guideline
focused on the prevention of stroke and the complications
associated with AF and was constructed on the basis of the
T. Nitta et al. / Journal of Arrhythmia 28 (2012) 338–346340evidence obtained from previous maze procedures. Surgery for AF
in patients undergoing surgery for mitral valve disease is recom-
mended as a class 1 indication because multiple studies have
demonstrated a signiﬁcantly lesser incidence of stroke
in patients undergoing a concomitant maze procedure compared
with those without. In AF patients undergoing other cardio-
vascular surgeries, AF surgery is recommended as a class IIa
indication.
In 2012, a revised consensus statement for AF surgery was
published by the Heart Rhythm Society/European Heart Rhythm
Association/European Cardiac Arrhythmia Society as a part of the
‘‘Expert consensus statement for catheter and surgical ablation for
AF’’ [7]. The statement was focused mainly on the relief of
symptoms associated with AF and the safety of the procedure,
as shown in Table 1.
The consensus conference of the International Society of
Minimally Invasive Cardiothoracic Surgery (ISMICS) aimed to
determine whether surgical AF ablation during cardiac surgery
improves the clinical and resource outcomes compared with
cardiac surgery alone in adults undergoing cardiac surgery for
valve or coronary artery bypass grafting [8,9]. The available
evidence, including systematic reviews, randomized trials, and
nonrandomized trials, was reviewed by the consensus panel and
considered in descending order of validity and importance. Then,
evidence-based statements were created and consensus processes
were done to determine the ensuing recommendations. Six
questions were formulated and statements were drawn for each
question, except for question 6, as shown in Table 2. Although the
evidence level was B and the class of recommendation was IIa, the
consensus panel reached an agreement that a concomitant
surgical ablation is recommended to reduce the risk of strokeTable 1
Consensus indications for catheter and surgical ablation of AF. (Cited from Ref. [7] wit
Indications for catheter ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic med
Paroxysmal: Catheter ablation is recommended*
Persistent: Catheter ablation is reasonable
Longstanding Persistent: Catheter ablation may be considered
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with a Class 1 or 3 an
Paroxysmal: Catheter ablation is reasonable
Persistent: Catheter ablation may be considered
Longstanding Persistent: Catheter ablation may be considered
Indications for concomitant surgical ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic med
Paroxysmal: Surgical ablation is reasonable for patients undergoing surgery for ot
Persistent: Surgical ablation is reasonable for patients undergoing surgery for othe
Longstanding persistent: Surgical ablation is reasonable for patients undergoing su
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with a Class 1 or 3 an
Paroxysmal: Surgical ablation is reasonable for patients undergoing surgery for ot
Persistent: Surgical ablation is reasonable for patients undergoing surgery for othe
Longstanding Persistent: Surgical ablation may be considered for patients undergo
Indications for stand alone surgical ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic med
Paroxysmal: Stand alone surgical ablation may be considered for patients who ha
Paroxysmal: Stand alone surgical ablation may be considered for patients who ha
Persistent: Stand alone surgical ablation may be considered for patients who have
Persistent: Stand alone surgical ablation may be considered for patients who have
Longstanding Persistent: Stand alone surgical ablation may be considered for patients
Longstanding Persistent: Stand alone surgical ablation may be considered for pati
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with a Class 1 or 3 an
Paroxysmal: Stand alone surgical ablation is not recommended
Persistent: Stand alone surgical ablation is not recommended
Longstanding Persistent: Stand alone surgical ablation is not recommended
n Catheter ablation of symptomatic paroxysmal AF is considered a Class 1 indicati
training and is performing the procedure in an experienced center.and thromboembolic events and improve the long-term survival
of patients (Fig. 2).3. Surgery for failed catheter ablation for lone AF
Although most patients with paroxysmal AF are effectively
treated by catheter ablation, one or more additional sessions of
ablation are required in some of these patients and in a consider-
able number of those with persistent or long-standing persistent AF.
Ad et al. [10] performed the maze procedure in 40 patients with
recurrent AF who underwent at least one left-sided ablation. Ninety-
ﬁve percent of the patients presented with long-standing persistent
AF. Careful inspection of the left atrial endocardial surface revealed
multiple spots of scar tissue, but with no deﬁnite linear or
continuous scar formation. At the time of the operation and before
surgical ablation, 96 PVs were assessed for an exit block. Ninety-ﬁve
percent of the veins tested were found to conduct across the
ablation line, even though all tested veins had a documented
conﬁrmed conduction block at the time of percutaneous catheter
ablation. After the maze procedure, the sinus rhythm was main-
tained in 76%, 89%, and 93% of the patients during the follow-up
periods of 6, 12, and 24 months, respectively, without taking class I/
III antiarrhythmic drugs (Fig. 3).4. Minimally invasive surgery for lone AF
The minimally invasive surgical procedure was developed for
patients with lone AF without any structural heart disease. The
procedure includes PV isolation with or without connectingh permission.)
Class Level
ication
I A
IIa B
IIb B
tiarrhythmic agent
IIa B
IIb C
IIb C
ication
her indications IIa C
r indications IIa C
rgery for other indications IIa C
tiarrhythmic agent
her indications IIa C
r indications IIa C
ing surgery for other indications IIb C
ication
ve not failed catheter ablation but prefer a surgical approach IIb C
ve failed one or more attempts at catheter ablation IIb C
not failed catheter ablation but prefer a surgical approach IIb C
failed one or more attempts at catheter ablation IIb C
who have not failed catheter ablation but prefer a surgical approach IIb C
ents who have failed one or more attempts at catheter ablation IIb C
tiarrhythmic agent
III C
III C
III C
on only when performed by an electrophysiologist who has received appropriate
Fig. 2. Meta-analysis of stroke or thromboembolism at latest follow-up. (Cited from Ref. [8] with permission: Innovations. 2010;5:84–96.)
Table 2
A consensus statement of the ISMICS 2009. (Modiﬁed from Ref. [9] with permission.)
Question 1: Does Surgical Ablation Result in Higher Rates of Sinus Rhythm Prior at Discharge and is the Effect Sustained Long-Term (6 Months, 1 Year, 3 Years, and
5 Years)?
Statement: In patients with AF undergoing cardiac surgery, surgical ablation improves the achievement of sinus rhythm at discharge and 1 year (level A).
This effect is sustained up to 5 years (level B).
Question 2: In Patients Undergoing Cardiac Surgery, Does Surgical AF Ablation Reduce the Need for Pharmacologic Treatment of AF, DC Cardioversion, or Pacemaker
Insertion?
Statements:
i. In patients with AF undergoing cardiac surgery, surgical ablation did not reduce the use of antiarrhythmic drugs at 12 months after surgery (level A;
36.0% vs. 45.4%), although trials were not designed to answer this question.
ii. In patients with AF undergoing cardiac surgery, surgical ablation did not increase the requirement for permanent pacemaker implantation (4.4% vs.
4.8%; level A), although level B evidence raises the possibility of increased need for pacemaker.
Question 3: In Patients Undergoing Cardiac Surgery, Does Surgical AF Ablation Reduce the Risk of Stroke, MI, Heart Failure, and Other Complications?
Statements:
i. In patients with AF undergoing cardiac surgery, surgical ablation does not increase the risk of perioperative mortality (level A), stroke (level A), MI
(level B), cardiac tamponade (level A), reoperative bleeding (level A), esophageal injury (level B), low cardiac output (level A), intraaortic balloon (level
B), congestive heart failure (level B), EF (level B), pleural effusion (level A), pneumonia (level A), renal dysfunction (level B), mediastinitis (level A). The
incidence of esophageal injury remains low (level B).
ii. In patients with AF undergoing cardiac surgery, surgical ablation does not reduce mortality at 1 year (level A). There is a possible reduction in mortality
beyond 1 year (level B).There was no difference in stroke (level A), MI (level A), and heart failure (level B). EF is increased (þ4.1% over control; level A).
Question 4: Does Ablation Improve QOL, Functionality, or Other Patient-Reported Outcomes?
Statement: In patients undergoing cardiac surgery, surgical AF ablation:
i. Has been shown to improve exercise tolerance at 1 year (level A); however, the methodology used and the number of trials studying this outcome are
insufﬁcient.
ii. Has not been shown to impact QOL at 3 months and 1 year (level A); however, the methodology used and number of trials studying this outcome are
insufﬁcient.
Question 5: In Patients Undergoing Cardiac Surgery, Does Surgical AF Ablation Reduce Total Costs, ICU and Hospital Length of Stay, Need for Repeat Cardiac Surgery,
Readmissions, and Cost-Effective?
Statement: In patients undergoing cardiac surgery, concomitant surgical ablation increases CPB and cross-clamp times (level A), with no difference in ICU
and hospital length of stay (level A). Overall costs were not reported.
Question 6: In Patients With AF Undergoing Cardiac Surgery Plus Ablation, How Do Different Ablative Techniques Compare With Each Other for Conversion to Sinus
Rhythm Cut-and-Sew, Cox Maze I, II, and III, Pulmonary Vein Isolation, Radiofrequency Ablation, Ultrasound Ablation, Laser Ablation, and Cryoablation?
No statement.
T. Nitta et al. / Journal of Arrhythmia 28 (2012) 338–346 341lesions, excision or closure of the left atrial appendage, or ablation
of the active GP, performed through small thoracotomy or a
thoracoscopic approach. This procedure avoids the use of cardio-
pulmonary bypass, cardiac arrest, and a full sternotomy. Initially,
the indication of the minimally invasive procedure was paroxysmal
AF; however, more recently, it has been extended to persistent and
long-standing persistent AF [11]. Nevertheless, PV isolation alone
has been shown to be insufﬁcient in treating long-standing
persistent AF, and the need for connection lines between the PV
isolation lines and the mitral annulus has been raised [12]. Variousepicardial techniques were tested to create a linear block line on
the atrial free wall on the beating heart [13–16].
Compared with the full-maze procedure with cardiopulmon-
ary bypass, cardiac arrest, and full sternotomy, the minimally
invasive procedure reduces the potential risk of bleeding,
myocardial damage and other complications, and mortality. PV isola-
tion can be performed both with catheter ablation and surgical
ablation. Sauren et al. [17] investigated the occurrence of cerebral
microembolic signals as a surrogate marker for the risk of neurolo-
gical impairment of 2 different PV isolation methods: percutaneous
Fig. 4. Left atrial appendage (LAA) clip, deployment tool, and deployment. (A)
Reusable Miltex deployment tool, as used in all cases. The LAA clip is loaded onto
the jaws of this tool. (B) LAA mobilized within the clip (1), right pulmonary veins
(2), and pulmonary artery (3), and operator’s hand (4) gently mobilizing the heart
to demonstrate the LAA and allow placement of the clip with the left hand. (Cited
from Ref. [21]: J Thorac Cardiovasc Surg. 2010;139:1269-74.)
Fig. 3. Outcome after the maze procedure for patients with failed radiofrequency
catheter ablation. Return to sinus rhythm rate. (AA, antiarrhythmic drugs; NSR,
normal sinus rhythm; SR, sinus rhythm.) (Cited from Ref. [10] with permission:
Ann Thorac Surg. 2011;91:1371-7.)
T. Nitta et al. / Journal of Arrhythmia 28 (2012) 338–346342endocardial RF ablation and thoracoscopic epicardial ablation
with RF energy.
The incidences of AF and AT have been shown to be relatively
high after minimally invasive AF surgery [18–20]. Edgerton et al.
[18] demonstrated that freedom from AF or AT should be assessed
by long-term monitoring. Kron et al. [19] showed that 40% of
patients could undergo bilateral PV isolation and ablation of GP
and the ligament of Marshall through a minimally invasive thoraco-
scopic procedure. An electrophysiological study investigated
patients with atrial arrhythmias and found that the underlying
mechanism behind the arrhythmias was the reconnection of the
previous PV isolation and isthmus-dependent reentry. Zeng et al.
[20] examined patients with recurrent atrial tachyarrhythmias after
minimally invasive PV isolation with an electro-anatomical mapping
system, and found gaps at the roof and bottom of the PV isolation.
They also found gaps in the PV isolation ring and ectopic focus
between the left atrial appendage and left superior PV.Closure of the left atrial appendage is an important procedure
both in the full-maze and minimally invasive AF procedures, with
regard to the prevention of stroke. Staples have been used to close
the left atrial appendage in the minimally invasive AF procedure.
Recently, a new clip device was introduced and tested in animals
and patients [21,22] (Fig. 4). The initial results were favorable,
and further trials are required to test the long-term safety and to
evaluate the role of the left atrial appendage occlusion in stroke
prevention.5. Postoperative AT
Although the maze procedure is the gold standard in surgical
therapy for AF, the restoration ratio of sinus rhythm from AF is
about 90%. Five percent to 10% of patients experience recurrences
of AF or AT after the maze procedure [23]. While recurrent AF
occurs in some patients with a large left atrium (cardiothoracic
ratio 470% and left atrial diameter 480 mm) preoperatively, the
mechanism of postoperative AT differs from that of recurrent AF.
It has become clear that the most common mechanism of post-
operative AT is incomplete ablation of the mitral valve annulus
and coronary sinus. Wazni et al. [24] reported that incomplete
surgical ablation of the PVs, or the mitral or tricuspid annulus
causes postoperative AT after the traditional cut-and-sew maze
procedure. Postoperative AT is cured by catheter ablation of the
incomplete conduction block. McElderry et al. [25] described a
15% incidence of AT after a modiﬁed maze procedure. They found
macro-reentries around the surgical incisions caused by residual
conduction at the incomplete ablation site in AT patients.
The rationale behind the surgical treatment of AF is to create a
conduction block. The cut-and-sew technique provides a com-
plete conduction block, and a line of conduction block prevents
propagation of abnormal activation and interrupts reentrant
circuits. Alternative ablation devices have been developed to
replace the cut-and-sew lesions of the original maze procedure
in order to simplify the surgical procedure, decrease the risk of
bleeding, and shorten the cardiac arrest and operative times
during the surgery. However, ablation devices such as traditional
cryoablation, RF ablation, microwave, or ultrasound do not
necessarily guarantee a transmural and continuous necrosis.
However, Lall et al. [2] described that AF surgery with a RF
ablation device cured AF in 490% of patients, which is a similar
result to that with the traditional cut-and-sew maze procedure.
Stulak et al. [26] and Doty et al. [27] reported that the traditional
cut-and-sew maze procedure was superior to RF AF surgery for
the treatment of AF. Ishii et al. [28] emphasized the importance of
complete ablation of the coronary sinus and PVs during AF
surgery. They recommend an intraoperative evaluation of the
conduction block by pacing from the coronary sinus or PVs in
order to prevent postoperative AT (Fig. 5). Krul et al. [29]
demonstrated that the periprocedural conﬁrmation of ablation
lesions contributed in achieving a high success rate of thoraco-
scopic video-assisted PV antrum isolation with GP ablation. Henry
et al. [30] showed that recurrent AT can be safely and effectively
treated by catheter ablation postoperatively, suggesting that the
combination of catheter and surgical ablation can improve out-
come even in complex patients.6. Hybrid approach
A hybrid approach that combines surgical epicardial PV isolation
with an excision or closure of the left atrial appendage
and catheter-based endocardial ablation of the atrioventricular
isthmuses or focal ablation may enhance the advantages and lessen
Fig. 5. Conﬁrmation of pulmonary vein (PV) isolation. Each of the 4 PVs is paced using a bipolar electrode after PV ablation. The conduction block between the PVs and the
left atrium is determined by the failure of atrial capture despite the maximum output of the stimuli of the PV pacing. If any residual conduction is observed between any of
the PVs and the left atrium, repeat ablation is performed until a complete conduction block is conﬁrmed. Pacing sites (rectangles). Rt. PVs, right pulmonary veins; Lt. PVs,
left pulmonary veins. (Cited from Ref. [28]: J Thorac Cardiovasc Surg. 2008;136:998–1004.)
Fig. 6. Flow diagram of the stepwise lesion sets. CTI, cavotricuspid isthmus; LA, left atrium; NSR, normal sinus rhythm; PVI, pulmonary vein isolation; RA, right atrium.
(Cited from Ref. [33] with permission: J Am Coll Cardiol. 2012;60:54–61.)
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T. Nitta et al. / Journal of Arrhythmia 28 (2012) 338–346344the disadvantages of the other procedure and enable a minimally
invasive and effective treatment for AF. Surgical PV isolation is easily
and safely performed using a bipolar RF clamp-type device, and
several devices are available for the excision or closure of the left
atrial appendage. These procedures can be performed either through
small thoracotomy or by using a thoracoscope.
It is still not certain whether a single or a staged approach is safer
and more effective. Natale et al. [31] performed a combined closed-
chest epicardial monopolar radiofrequency ablation through a
transabdominal transdiaphragmatic single port and catheter-based
transseptal endocardial ablation as a single-stage approach in 22
patients with long-standing persistent AF and a large left atrium.
The outcome and complications were compared with those in
patients who underwent standard manual catheter ablation. The
hybrid approach resulted in 13.6% mortality rate, whereas no death
was reported in the standard approach. There was no signiﬁcant
difference in AF-free rate (55% vs. 54%) after a single procedure.
Mahapatra et al. [32] performed a sequential surgical epicar-
dial ablation followed by planned endocardial evaluation and
ablation during the same hospitalization in 15 patients who failed
at least 1 catheter ablation and treatment with 1 antiarrhythmic
drug, and compared the results with 30 patients who underwent
a repeat catheter ablation. Five of the surgical ablation patients
were inducible to atrial ﬂutter and were ablated. After a mean
follow-up of 2175 months, 86.7% of the surgical ablation
patients were free of atrial arrhythmias and off of antiarrhythmic
drugs, compared with 53.3% in catheter-alone patients.
More recently, Pison et al. [33] reported the 1-year follow-up
data of 26 patients who underwent a hybrid thoracoscopic
surgical and transvenous catheter ablation of AF. Epicardial PV
isolation with a bipolar RF clamp was tested endocardially, and
23% of the patients showed residual conduction across the lesion.
The lesion set was determined in a stepwise fashion (Fig. 6) and
performed epicardially and endocardially. The 1-year success rate
for AF was 93% in paroxysmal AF patients and 90% in persistent
AF patients.7. Challenges for advanced cases
A dilated left atrium, a longer duration of AF, the presence of
low-voltage f-waves on the electrocardiogram, and others haveFig. 7. Box lesion set. Patients either had a single ablation line connecting the
inferior right and left pulmonary veins (non-box lesion set) or had an additional
ablation line connecting the superior right and left pulmonary veins (box lesion
set), which electrically isolated the posterior left atrium. RF, radiofrequency. (Cited
from Ref. [37] with permission: J Thorac Cardiovasc Surg. 2008;135:870-7.)been reported as risk factors for unsuccessful outcome or AF
recurrence after the maze procedure. Damiano et al. [34]
conﬁrmed that an increasing size of the left atrium was a
signiﬁcant risk factor for failure of an ablation-assisted maze
procedure, and concluded that there might be a need for a more
extensive size reduction or expanded lesion sets in patients with a
large left atrium. Volume reduction procedures, such as resection
of the inferoposterior left atrium [35] or plication of the redun-
dant left atrium along the PV isolation line [36], demonstrated an
improved conversion rate of AF and increased left atrial function
postoperatively. Damiano et al. [34,37] have shown that the box
lesion set (Fig. 7), in which the bilateral PV isolation lines are
connected at the roof of the left atrium and the entire posterior
left atrium is isolated, decreased the incidence of early atrial
tachyarrhythmias and late recurrence of AF. Because the more the
atrial wall is isolated, the more the atrial transport function is
impaired, the indication of the box lesion set should be examined
in terms of atrial function in patients with different sizes of the
left atrium.8. Role of GP ablation
Increased autonomic nervous activity has long been known to
play a potentially important role in the initiation and mainte-
nance of AF. Vagal nerves innervate the heart more heteroge-
neously than the sympathetic nervous system, resulting in spatial
heterogeneity of refractoriness. Therefore, increased vagal activa-
tion may be more important than the effect of the sympathetic
discharge in the arrhythmogenesis of AF.
Recently, the identiﬁcation of the GPs and their ablation has
been expected to reduce the vagal activity that may facilitate the
triggered activity in the PVs and prevent the recurrence of AF
after surgical treatment. High-frequency stimulation at a rate of
800 beats/min is delivered to the fat pad beside the PVs and atrial
tissue; then, a speciﬁc area with a vagal reﬂex (reduction in heart
rate) during stimulation is deﬁned as an active GP. Mehall et al.
[38] ablated the GPs in a minimally invasive operation for AF.
Forty-one patients with paroxysmal and chronic AF underwent
the operation, and on average, 3 active GPs were identiﬁed in each
patient. More than half of the GPs were found in the area of the
superior aspect of the interatrial groove and the ligament of
Marshall. In addition to PV isolation, each GP was isolated or
ablated, resulting in the complete elimination of vagal reﬂexes
after the ablation. Mcclelland et al. [39] performed precise
mapping of GP activity in 21 patients with paroxysmal or
persistent AF. Their data showed that bilateral PV isolation
eliminated 79% of the GP active sites and additional GP ablation
achieved extensive elimination (94%) of GP activity. During a
mean follow-up time of 1773.5 months, there was only 1
recurrence in a patient with paroxysmal AF, while 4 of 9 patients
(44%) with persistent AF had postoperative recurrence. On the
other hand, Onorati et al. [40] reported that GP ablation combined
with the maze procedure improved the short-term outcome
compared with the maze procedure alone in the treatment of
persistent AF during mitral valve surgery.
GP ablation has been regarded as a vagal denervation proce-
dure that reduces the vagal tone in the atria and the vulnerability
to AF. However, it is unclear how much vagal effect on the atrium
is attenuated and how much of the atrium is denervated after the
ablation. According to the GP mapping by Mcclelland et al. [39], a
vagal reﬂex was present in the GPs near the atrioventricular
groove even after the ablation. A histoanatomical study showed
that more than 700 ganglions and 40,000 neurons are distributed
in the whole atria and linked with each other. These data suggest
that it is difﬁcult to eliminate every GP activity to exclude all
Fig. 8. Mean QRST area changes at 5 atrial regions before ablation (Pre-Ab),
immediately after ablation (Post-Ab), and 4 weeks after ablation. Signiﬁcantly
increased area changes against control values (po0.05) are indicated by shading.
stim, stimulation. (Cited from Ref. [42] with permission: J Thorac Cardiovasc Surg.
2010;139:444-52.)
T. Nitta et al. / Journal of Arrhythmia 28 (2012) 338–346 345neural networks from the atrium. Lall et al. [41] examined the
vagal denervation effects after a maze IV procedure with canine
atria, and showed that the maze procedure partially denervated
the atrium. However, Voeller et al. [37] demonstrated in patients
that the box lesion isolating the entire posterior left atrium in the
maze III procedure showed a signiﬁcantly higher freedom from AF
compared with a single connecting lesion between the inferior
PVs, suggesting that connecting the lesion between the superior
PVs denervated the GPs more extensively in the left atrial roof.
More recently, Sakamoto et al. [42] examined the electrophysio-
logic attenuation and recovery of the atrial vagal effects after GP
ablation alone or with standard surgical lesion sets for AF. They
demonstrated that GP ablation signiﬁcantly reduced atrial vagal
innervation with restoration of vagal effects at 4 weeks, suggesting
early atrial reinnervation (Fig. 8).9. Future perspective
The results of the surgery for AF are still less than satisfactory. This
is largely because of the various and undetermined underlying
mechanisms for the initiation and sustenance of AF in each patient.
These mechanisms include atrial electro-pathophysiological abnorm-
alities, autonomic nerve activity, and others. Therefore, no single
surgical procedure may be sufﬁcient to cure all types of AF in every
patient. A new modality is needed to examine each patient preopera-
tively or intraoperatively, in order to ‘‘characterize’’ the AF and then
determine the ideal surgical procedure for each individual. The hybrid
procedure combining epicardial and endocardial ablation with a
stepwise approach may enable the development of a tailor-made
therapy for AF.Conﬂict of interest
There is no conﬂict of interest.
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